[Ip-health] MSF urges negotiators to drop harmful provisions from RCEP agreement

Joanna Keenan joanna.l.keenan at gmail.com
Mon Aug 24 07:37:09 PDT 2015


MSF urges negotiators to drop harmful provisions from RCEP agreement

https://www.msfaccess.org/about-us/media-room/press-releases/msf-statement-rcep-trade-negotiations-kuala-lumpur


As the trade ministers of the 16 countries negotiating the Regional
Comprehensive Economic Partnership (RCEP) meet in Kuala Lumpur this week to
finalise provisions in the deal, Doctors Without Borders/Médecins Sans
Frontières (MSF) is calling for the removal of damaging intellectual
property provisions in the deal that would risk locking in high drug prices
and endangering the health of millions of people across the globe.


RCEP is a regional trade agreement being negotiated between the 10 ASEAN
(Association of Southeast Asian Nations) countries and Australia, China,
India, Japan, New Zealand and South Korea. To date, nine rounds of
negotiations have taken place.  The leaked text
<http://www.keionline.org/node/2239> of the proposal put forth by Japan and
other developed countries includes harmful intellectual property provisions
such as patent term extensions, data exclusivity, lowering the bar on
patentability criteria, and excessive IP enforcement, all of which extend
monopoly protection beyond what is required by existing international
agreements.



*“Treatment scale up for diseases like HIV and TB has only been made
possible in many developing countries due to the availability of affordable
generic drugs manufactured in India. The world is now looking at India
again to provide affordable generic medicines such as those used in the
treatment of hepatitis C, which affects up to 150 million people worldwide.
*


*“If India and other negotiating countries accept the proposed text **on
intellectual property rights being pushed in RCEP**, it **will roll back
public health safeguards enshrined in international and national laws, and
will put in place far-reaching monopoly protections that restrict generic
competition and make medicine prices unaffordable for millions of people
who need them.”*


* - Leena Menghaney, Head-South Asia, MSF Access Campaign*




Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
P: +41 22 849 87 45
M: +41 79 203 13 02
E: joanna.keenan[at]geneva.msf.org
T: @joanna_keenan

msfaccess.org
twitter.com/MSF_access
facebook.com/MSFaccess



More information about the Ip-health mailing list